Cornerstone Capital, Inc. Abbott Laboratories Transaction History

Cornerstone Capital, Inc.

$988 Million
Q2 2024

A detailed history of Cornerstone Capital, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Cornerstone Capital, Inc. holds 240,158 shares of ABT stock, worth $27.2 Million. This represents 2.53% of its overall portfolio holdings.

Number of Shares

240,158

Previous 241,843 0.7%

Holding current value

$27.2 Million

Previous $27.5 Million 9.22%

% of portfolio

2.53%

Previous 2.83%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$100.73 - $112.44 $169,730 - $189,461	-1,685 Reduced 0.7%	240,158 $25 Million
Q1 2024 May 01, 2024	BUY	$109.52 - $120.96 $22,232 - $24,554	203 Added 0.08%	241,843 $27.5 Million
Q4 2023 Feb 02, 2024	SELL	$90.19 - $110.4 $1.01 Million - $1.23 Million	-11,176 Reduced 4.42%	241,640 $26.6 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $225,737 - $270,847	-2,363 Reduced 0.93%	252,816 $24.5 Million
Q2 2023 Aug 21, 2023	SELL	$100.78 - $112.29 $869,932 - $969,287	-8,632 Reduced 3.27%	255,179 $27.8 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $464,637 - $546,905	4,797 Added 1.85%	263,811 $26.7 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $55,324 - $64,904	-582 Reduced 0.22%	259,014 $28.4 Million
Q3 2022 Oct 27, 2022	BUY	$96.76 - $112.03 $518,923 - $600,816	5,363 Added 2.11%	259,596 $25.1 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $484,424 - $585,514	-4,746 Reduced 1.83%	254,233 $27.6 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $399,640 - $487,335	-3,505 Reduced 1.34%	258,979 $30.7 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $34,312 - $42,013	-297 Reduced 0.11%	262,484 $36.9 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $551,568 - $610,195	-4,728 Reduced 1.77%	262,781 $31 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $674,517 - $794,003	6,376 Added 2.44%	267,509 $31 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $647,706 - $763,096	-5,951 Reduced 2.23%	261,133 $31.3 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $1.05 Million - $1.15 Million	-10,023 Reduced 3.62%	267,084 $29.2 Million
Q3 2020 Oct 27, 2020	SELL	$91.64 - $111.29 $64,972 - $78,904	-709 Reduced 0.26%	277,107 $30.2 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $731,702 - $936,488	-9,556 Reduced 3.33%	277,816 $25.4 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $399,723 - $584,505	-6,363 Reduced 2.17%	287,372 $22.7 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $1.19 Million - $1.32 Million	15,142 Added 5.44%	293,735 $25.5 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $1.73 Million - $1.88 Million	-21,178 Reduced 7.06%	278,593 $23.3 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $109,320 - $127,500	1,500 Added 0.5%	299,771 $25.2 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $704,315 - $851,518	-10,636 Reduced 3.44%	298,271 $23.8 Million
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $217,528 - $246,427	-3,318 Reduced 1.06%	308,907 $22.3 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $62,755 - $75,707	-1,032 Reduced 0.33%	312,225 $22.9 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $224,753 - $248,060	-3,904 Reduced 1.23%	313,257 $19.1 Million
Q1 2018 May 08, 2018	BUY	$56.27 - $63.62 $128,970 - $145,817	2,292 Added 0.73%	317,161 $19 Million
Q4 2017 Feb 12, 2018	SELL	$53.68 - $57.47 $132,589 - $141,950	-2,470 Reduced 0.78%	314,869 $18 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $15.3 Million - $17 Million	317,339	317,339 $16.9 Million

Others Institutions Holding ABT

# of Institutions

3,131

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Capital, Inc. with notifications on news.

Account

Cornerstone Capital, Inc. Abbott Laboratories Transaction History